# US 2025/0147053 A1 · Mass spectrometry assay for congenital adrenal hyperplasia

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0147053 A1
- Document ID: US20250147053A1
- Status: Published application
- Kind: A1
- Application number: 19/008,056
- Filed: 2025-01-02
- Published: 2025-05-08
- Earliest claimed: 2008-12-24
- Assignees: Quest Diagnostics Investments Incorporated
- Applicants: Quest Diagnostics Investments LLC
- Inventors: Amit Ghoshal; Nigel J. Clarke; Mildred M. Goldman
- Web page: https://patentgrep.com/patent/US20250147053A1

## CPC

- G01N 33/743: {Steroid hormones}
- G01N 30/7233: {interfaced to liquid or supercritical fluid chromatograph (interfaces in general for introducing or extracting samples to be analysed with specially adapted mass spectrometer, see H01J49/04)}
- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- G01N 33/6851: {Methods of protein analysis involving laser desorption ionisation mass spectrometry}
- G01N 33/689: {related to pregnancy or the gonads}
- H01J 49/0031: {Step by step routines describing the use of the apparatus (H01J49/0081 takes precedence)}
- H01J 49/004: {Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn}
- H01J 49/165: {Electrospray ionisation}
- C12Q 1/6872: involving mass spectrometry
- G01N 2560/00: Chemical aspects of mass spectrometric analysis of biological material
- G01N 2800/04: Endocrine or metabolic disorders
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- H01J: ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS (spark-gaps H01T; electric arc lamps H05B31/00; particle accelerators H05H)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

A method for determining the amount of a panel of analytes in a sample by mass spectrometry includes purifying the sample by liquid chromatography; ionizing the sample under conditions suitable to produce one or more ions detectable by mass spectrometry from each of the analytes comprising dehydroepiandrosterone (DHEA), cortisol, and androstenedione; determining by tandem mass spectrometry the amount of the one or more ions from each of the analytes; and using the determined amount of the one or more ions to determine the amount of each of the analytes in the sample.

## Claims

### Claim 1

A method for determining the amount of a panel of analytes in a sample by mass spectrometry, the method comprising:
purifying the sample by liquid chromatography;
ionizing the sample under conditions suitable to produce one or more ions detectable by mass spectrometry from each of the analytes comprising dehydroepiandrosterone, cortisol, and androstenedione;
determining by tandem mass spectrometry the amount of the one or more ions from each of the analytes; and
using the determined amount of the one or more ions to determine the amount of each of the analytes in the sample.

### Claim 2 (depends on 1)

The method of claim 1, wherein the liquid chromatography is selected from the group consisting of high performance liquid chromatography, ultra high performance liquid chromatography, and turbulent flow liquid chromatography.

### Claim 3 (depends on 1)

The method of claim 1, wherein the sample has been purified by turbulent flow liquid chromatography and either high performance liquid chromatography or ultra high performance liquid chromatography prior to being subjected to an ionization source.

### Claim 4 (depends on 1)

The method of claim 1, wherein an internal standard is used for determination of the amounts of the analytes in the sample.

### Claim 5 (depends on 4)

The method of claim 4, wherein the internal standard comprises an isotopically labeled analogue of one of the analytes.

### Claim 6 (depends on 1)

The method of claim 1, wherein the sample comprises a biological sample.

### Claim 7 (depends on 6)

The method of claim 6, wherein the sample comprises plasma or serum.
